Aurobindo Pharma Ltd — Dapagliflozin Exporter Profile
Indian Pharmaceutical Exporter · #14 for Dapagliflozin · $688.9K export value · DGFT Verified
Aurobindo Pharma Ltd is the #14 Indian exporter of Dapagliflozin with $688.9K in export value and 51 verified shipments. Aurobindo Pharma Ltd holds a 1.4% market share in Dapagliflozin exports across 2 countries.
Aurobindo Pharma Ltd — Dapagliflozin Export Profile: Buyers & Destinations
Where Does Aurobindo Pharma Ltd Export Dapagliflozin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $1.0M | 73 | 100.0% |
| MALTA | $2 | 2 | 0.0% |
Aurobindo Pharma Ltd exports Dapagliflozin to 2 countries. The largest destination is CANADA accounting for 100.0% of Aurobindo Pharma Ltd's Dapagliflozin shipments. These destinations reflect Aurobindo Pharma Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Dapagliflozin from Aurobindo Pharma Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AURO PHARMA INC | CANADA | $725.7K | 56 |
| AURO PHARMA INC, | CANADA | $212.0K | 15 |
| AURO PHARMA INC, C/O LYNDEN | CANADA | $81.7K | 2 |
| APL SWIFT SERVICES (MALTA) LTD. | MALTA | $2 | 2 |
Aurobindo Pharma Ltd supplies Dapagliflozin to 4 buyers globally. The largest buyer is AURO PHARMA INC (CANADA), followed by AURO PHARMA INC, (CANADA) and AURO PHARMA INC, C/O LYNDEN (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Dapagliflozin Export Value and How Much Does Aurobindo Pharma Ltd Contribute?
India exported $34.4M worth of Dapagliflozin through 5,104 shipments from 254 suppliers to 113 countries, serving 502 buyers globally. Aurobindo Pharma Ltd contributes $688.9K to this total, accounting for 1.4% of India's Dapagliflozin exports. Aurobindo Pharma Ltd ships Dapagliflozin to 2 countries through 4 buyers.
What Is the Average Shipment Value for Aurobindo Pharma Ltd's Dapagliflozin Exports?
Aurobindo Pharma Ltd's average Dapagliflozin shipment value is $13.5K per consignment, based on 51 shipments totaling $688.9K. The largest destination is CANADA (100.0% of Aurobindo Pharma Ltd's Dapagliflozin exports).
How Does Aurobindo Pharma Ltd Compare to Other Indian Dapagliflozin Exporters?
Aurobindo Pharma Ltd ranks #14 among 254 Indian Dapagliflozin exporters with a 1.4% market share. The top 3 exporters are MICRO LABS LIMITED ($7.7M), AJANTA PHARMA LIMITED ($5.2M), ALEMBIC PHARMACEUTICALS LIMITED ($4.8M). Aurobindo Pharma Ltd processed 51 shipments to 2 destination countries.
What Dapagliflozin Formulations Does Aurobindo Pharma Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DAPAGLIFLOZIN AND METFORMIN HCL EXTENDED | $88.6K | 5 |
| DAPAGLIFLOZIN AND METFORMIN HCL EXTENDED -RELEASE TABLETS 5MG/1000 MG(AURO-DAPAGLIFLOZIN-METFORMIN 5 MG / 1000)60'S | $86.3K | 4 |
| DAPAGLIFLOZIN AND METFORMIN HCL EXTENDED-RELEASE TABLETS 5MG/1000MG(AURO-DAPAGLIFLOZIN-METFORMIN 5MG/1000)500S(2928PACK)NOS | $51.0K | 3 |
| DAPAGLIFLOZIN AND METFORMIN HCL EXTENDED -RELEASE TABLETS 5MG/1000MGAuro-Dapagliflozin-Metformin 5mg/100060S25680PACK | $50.0K | 1 |
| DAPAGLIFLOZIN AND METFORMIN HCL EXTENDED -RELEASE TABLETS 5MG/1000MG(AURO-DAPAGLIFLOZIN-METFORMIN 5MG/1000)60S(31008PACK | $50.0K | 1 |
| DAPAGLIFLOZIN AND METFORMIN HCL EXTENDED -RELEASE TABLETS 5MG/1000 MG(AURO-DAPAGLIFLOZIN-METFORMIN 5 MG / 1000)100'S | $50.0K | 1 |
| DAPAGLIFLOZIN AND METFORMIN HCL EXTENDED RELEASE TABLETS 5MG/1000 MGAuro-Dapagliflozin-Metformin 5mg/100025608 PACKS | $49.0K | 1 |
| DAPAGLIFLOZIN&METFORMIN HYDROCHLORIDE TABS5MG/850MG(AURO-DAPAGLIFLOZIN-METFORMIN5MG/850)60'S(QTY:15552PAK) | $42.6K | 1 |
| DAPAGLIFLOZIN & METFORMIN HCL EXTENDED - RELEASE TABLETS 5MG/1000MG(AURO-DAPAGLIFLOZIN-METFORMIN 5MG/1000)500S(2315PACK) | $42.0K | 1 |
| DAPAGLIFLOZIN AND METFORMIN HCL EXTENDED-RELEASE TABLETS 5MG/1000MG(AURO-DAPAGLIFLOZIN-METFORMIN5 MG/1000)60S(21984PACK) | $40.5K | 1 |
Aurobindo Pharma Ltd exports 43 distinct Dapagliflozin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DAPAGLIFLOZIN AND METFORMIN HCL EXTENDED with 5 shipments worth $88.6K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Dapagliflozin to Key Markets
What Aurobindo Pharma Ltd must comply with to export Dapagliflozin to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Aurobindo Pharma Ltd Compare to Nearest Dapagliflozin Exporters?
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | SANDOZ PRIVATE LIMITED | $1.1M | 44 | 3 | $25.9K |
| 11 | MSN LABORATORIES PRIVATE LIMITED | $825.0K | 42 | 8 | $19.6K |
| 14 | AUROBINDO PHARMA LTD ★ | $688.9K | 51 | 2 | $13.5K |
| 15 | SAVA HEALTHCARE LIMITED | $681.6K | 535 | 2 | $1.3K |
| 12 | EXEMED PHARMACEUTICALS | $400.0K | 8 | 2 | $50.0K |
Aurobindo Pharma Ltd ranks #14 among 254 Indian Dapagliflozin exporters. Average shipment value of $13.5K compared to the market average of $135.5K. The closest competitors by value are SANDOZ PRIVATE LIMITED and MSN LABORATORIES PRIVATE LIMITED.
Which Indian Ports Ship Dapagliflozin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,003 | 19.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 791 | 15.5% |
| DELHI AIR CARGO ACC (INDEL4) | 761 | 14.9% |
| DELHI AIR | 612 | 12.0% |
| Bombay Air | 194 | 3.8% |
| BANGALORE ACC (INBLR4) | 189 | 3.7% |
| BANGALORE AIR | 160 | 3.1% |
| NHAVA SHEVA SEA (INNSA1) | 136 | 2.7% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Dapagliflozin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Dapagliflozin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aurobindo Pharma Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 75 individual customs records matching Aurobindo Pharma Ltd exporting Dapagliflozin, covering 43 formulations to 2 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 113+ countries, 502+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Dapagliflozin Export Data from Aurobindo Pharma Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Ltd's Dapagliflozin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Ltd
Company Profile
0 products · $0 total trade · 0 categories
Dapagliflozin Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Dapagliflozin. For current shipment-level data, contact TransData Nexus.